• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥散性血管内凝血患者的血浆组织因子和组织因子途径抑制物水平

Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.

作者信息

Shimura M, Wada H, Wakita Y, Nakase T, Hiyoyama K, Nagaya S, Mori Y, Shiku H

机构信息

Second Department of Internal Medicine, Mie University School of Medicine, Tsu-city, Mie-ken, Japan.

出版信息

Am J Hematol. 1997 Aug;55(4):169-74. doi: 10.1002/(sici)1096-8652(199707)55:4<169::aid-ajh1>3.0.co;2-q.

DOI:10.1002/(sici)1096-8652(199707)55:4<169::aid-ajh1>3.0.co;2-q
PMID:9257875
Abstract

We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPI and vascular endothelial cell injury. Plasma TF (273 +/- 90 pg/ml) and TFPI (252 +/- 125 ng/ml) levels were significantly increased in patients with DIC compared with non-DIC patients. Plasma TF antigen level was significantly increased in pre-DIC patients (285 +/- 85 pg/ml), while the plasma TFPI level (152 +/- 54 ng/ml) was not markedly increased in such a state. The plasma TF/TFPI ratio was high in the pre-DIC patients (2.10 +/- 0.90), and low in the DIC patients (1.40 +/- 0.87) and healthy volunteers (0.84 +/- 0.26). There was no significant difference between the DIC patients with a good outcome and those with a poor outcome in terms of plasma TF levels, although the plasma TFPI level in the DIC patients with a good outcome (289 +/- 133 ng/ml) was significantly higher than those with a poor outcome (187 +/- 75 ng/ml). During the clinical course of DIC, plasma TF antigen was increased first, and an increase of the plasma TFPI level followed the increase in plasma TF level. These findings suggest that plasma TFPI is released from vascular endothelial cells and it may reflect vascular endothelial cell injury. It is conceivable that TF and TFPI may play an important role in the onset of DIC.

摘要

我们检测了弥散性血管内凝血(DIC)患者血浆中组织因子(TF)和组织因子途径抑制物(TFPI)的水平,以研究TFPI与血管内皮细胞损伤之间的关系。与非DIC患者相比,DIC患者血浆TF(273±90 pg/ml)和TFPI(252±125 ng/ml)水平显著升高。DIC前期患者血浆TF抗原水平显著升高(285±85 pg/ml),而在此状态下血浆TFPI水平(152±54 ng/ml)未明显升高。DIC前期患者血浆TF/TFPI比值较高(2.10±0.90),DIC患者(1.40±0.87)和健康志愿者(0.84±0.26)该比值较低。DIC患者中预后良好者与预后不良者的血浆TF水平无显著差异,尽管预后良好的DIC患者血浆TFPI水平(289±133 ng/ml)显著高于预后不良者(187±75 ng/ml)。在DIC的临床过程中,血浆TF抗原首先升高,随后血浆TFPI水平随血浆TF水平升高而升高。这些发现提示血浆TFPI从血管内皮细胞释放,可能反映血管内皮细胞损伤。可以推测TF和TFPI在DIC的发生中可能起重要作用。

相似文献

1
Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.弥散性血管内凝血患者的血浆组织因子和组织因子途径抑制物水平
Am J Hematol. 1997 Aug;55(4):169-74. doi: 10.1002/(sici)1096-8652(199707)55:4<169::aid-ajh1>3.0.co;2-q.
2
Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.弥散性血管内凝血患者的血浆组织因子和组织因子途径抑制物水平
Am J Hematol. 1996 Jul;52(3):165-70. doi: 10.1002/(SICI)1096-8652(199607)52:3<165::AID-AJH5>3.0.CO;2-R.
3
Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor.弥散性血管内凝血中的血浆组织因子途径抑制物:其与血浆组织因子表现的比较
Thromb Res. 1995 Nov 15;80(4):339-48. doi: 10.1016/0049-3848(95)00185-t.
4
Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation.弥散性血管内凝血临床过程中血浆组织因子途径抑制物水平的变化
Blood Coagul Fibrinolysis. 1998 Sep;9(6):491-7. doi: 10.1097/00001721-199809000-00006.
5
Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.弥散性血管内凝血患者血浆组织因子途径抑制物截短形式水平升高。
Am J Hematol. 1999 Feb;60(2):94-8. doi: 10.1002/(sici)1096-8652(199902)60:2<94::aid-ajh2>3.0.co;2-a.
6
Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜患者血浆组织因子途径抑制物水平降低。
Thromb Haemost. 1995 Jan;73(1):10-4.
7
[Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].[不同疾病患者血浆组织因子及组织因子途径抑制物的行为分析]
Rinsho Ketsueki. 1996 Sep;37(9):794-8.
8
Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation.弥散性血管内凝血患者血浆中组织因子途径抑制物激活的X因子复合物水平升高。
Am J Hematol. 2000 Nov;65(3):210-4. doi: 10.1002/1096-8652(200011)65:3<210::aid-ajh6>3.0.co;2-p.
9
Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.针对组织因子途径抑制物-因子Xa复合物的单克隆抗体:其特性及在弥散性血管内凝血和弥散性血管内凝血前期患者血浆中的应用
Blood Coagul Fibrinolysis. 1999 Sep;10(6):309-19.
10
Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients.组织因子途径抑制物反应与创伤患者中组织因子诱导的弥散性血管内凝血及多器官功能障碍综合征不相关。
Crit Care Med. 2001 Feb;29(2):262-6. doi: 10.1097/00003246-200102000-00006.

引用本文的文献

1
Challenges with measuring tissue factor antigen and activity in human plasma.测量人血浆中组织因子抗原和活性的挑战。
Blood Vessel Thromb Hemost. 2024 Jul 31;1(4):100022. doi: 10.1016/j.bvth.2024.100022. eCollection 2024 Dec.
2
Evaluation of the ability of commercial enzyme-linked immunosorbent assays to measure mouse tissue factor.评估商业酶联免疫吸附测定法检测小鼠组织因子的能力。
Res Pract Thromb Haemost. 2024 Jan 26;8(1):102325. doi: 10.1016/j.rpth.2024.102325. eCollection 2024 Jan.
3
Evaluation of four commercial ELISAs to measure tissue factor in human plasma.
评估四种用于检测人血浆中组织因子的商业酶联免疫吸附测定法。
Res Pract Thromb Haemost. 2023 Mar 28;7(3):100133. doi: 10.1016/j.rpth.2023.100133. eCollection 2023 Mar.
4
Proteomic profile of extracellular vesicles in maternal plasma of women with fetal death.母体外周血中胎儿死亡患者的细胞外囊泡的蛋白质组学特征。
J Matern Fetal Neonatal Med. 2023 Dec;36(1):2177529. doi: 10.1080/14767058.2023.2177529.
5
Recent advances in pathophysiology of disseminated intravascular coagulation: the role of circulating histones and neutrophil extracellular traps.弥散性血管内凝血病理生理学的最新进展:循环组蛋白和中性粒细胞胞外陷阱的作用
F1000Res. 2017 Dec 18;6:2143. doi: 10.12688/f1000research.12498.1. eCollection 2017.
6
Disseminated intravascular coagulation.弥散性血管内凝血
Indian J Anaesth. 2014 Sep;58(5):603-8. doi: 10.4103/0019-5049.144666.
7
Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes.胎盘血管病理学和凝血酶生成增加作为产科综合征疾病的机制。
PeerJ. 2014 Nov 18;2:e653. doi: 10.7717/peerj.653. eCollection 2014.
8
Bothrops jararaca venom metalloproteinases are essential for coagulopathy and increase plasma tissue factor levels during envenomation.巴西矛头蝮蛇毒金属蛋白酶对于中毒时的凝血病至关重要,并会增加血浆组织因子水平。
PLoS Negl Trop Dis. 2014 May 15;8(5):e2814. doi: 10.1371/journal.pntd.0002814. eCollection 2014 May.
9
Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis.自噬介导血栓形成组织因子向人脓毒症中性粒细胞细胞外陷阱的传递。
PLoS One. 2012;7(9):e45427. doi: 10.1371/journal.pone.0045427. Epub 2012 Sep 19.
10
High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor.早产患者的组织因子活性高且组织因子途径抑制物浓度低。
J Matern Fetal Neonatal Med. 2010 Jan;23(1):23-33. doi: 10.3109/14767050902994770.